Everest Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Everest Management's LLY Position: Q3 2026 in Review
Everest Management increased its Eli Lilly (LLY) stake by 27% in Q3 2026, buying an estimated $165K and bringing the position to 651 shares worth $753K. The position accounts for 0.25% of the portfolio, ranked #46.
Everest Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Everest Management held 651 shares of Eli Lilly worth $753K as of Q3 2026.
- Everest Management bought 140 Eli Lilly shares in Q3 2026, an estimated $165K.
- Eli Lilly made up 0.25% of Everest Management's portfolio in Q3 2026, its #46 holding.
- Everest Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Everest Management's 13F filing for Q3 2026, filed 10 Nov 2026.